[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 11, 1978

Sense With Cimetidine

Author Affiliations

USN National Naval Medical Center Uniformed Services University of the Health Sciences Bethesda, Md

JAMA. 1978;240(6):564. doi:10.1001/jama.1978.03290060066022

Recent investigations into histamine pharmacology have shown the presence of two classes of histamine receptors analogous to the two types of receptors (a and β) for adrenergic stimulation.1 These studies have resulted in the current understanding that long-known histamine effects like bronchial constriction and capillary dilation are due to stimulation of H1 histamine receptors, these effects being blocked by the classical antihistaminic agents (H1 receptor antagonists). Other actions of histamine, such as its ability to promote acid production from the gastric parietal cell, are now known to be due to stimulation of a distinct histamine receptor, which is designated as an H2 receptor.

The recent research into histamine pharmacology has resulted in the development of a series of compounds that specifically block the H2 histamine receptor.1 In fact, at the annual meeting of the American Gastroenterological Association in the spring of 1974, great excitement was generated by